Skip to content

Maleimide-Thiol Conjugation Enables the Optimization of 68Ga-Labeled CAIX Targeting PET Probes.

Oct 2026 · Journal of Medicinal Chemistry · Vol 69 20, pp. 24053-24067 · 0 citations · 45 references
Medicine

TL;DR

Four 68Ga-labeled CAIX-targeting probes based on the acetazolamide (AAZ) scaffold are reported, employing distinct conjugation strategies, including amide coupling and maleimide-thiol ligation, representing a promising candidate for imaging CAIX-overexpressing tumors and supporting clinical translation.

Abstract

Carbonic anhydrase IX (CAIX) is a well-established biomarker of tumor hypoxia and an attractive target for molecular imaging. Despite the development of small-molecule CAIX-targeting positron emission tomography (PET) probes, most exhibit high normal-organ uptake and suboptimal tumor-to-background contrast. Moreover, their application in hypoxic tumors remains insufficiently explored. Herein, we reported four 68Ga-labeled CAIX-targeting probes based on the acetazolamide (AAZ) scaffold, employing distinct conjugation strategies, including amide coupling and maleimide-thiol ligation. All probes demonstrated detectable tumor uptake in vivo. Among them, [68Ga]Ga-SMIC-2607 displayed the highest tumor uptake (14.67 ± 3.06 %ID/g) and tumor-to-kidney ratio (1.69 ± 0.41) at 1 h in subcutaneous OS-RC-2-bearing mice, along with high tumor uptake in HT-29-bearing mice (2.98 ± 0.28 %ID/g at 1 h). Overall, [68Ga]Ga-SMIC-2607 demonstrates favorable imaging characteristics, with high tumor uptake and high tumor-to-normal organ ratios, representing a promising candidate for imaging CAIX-overexpressing tumors and supporting clinical translation.

View source

Similar papers

Oct 2026

Enhancing the Specificity of the CAIX-Targeted Radionuclide Probe via the Optimization Cyclic Peptide Cyclization Linker

Carbonic anhydrase IX (CAIX) is a key biomarker for clear cell renal cell carcinoma (ccRCC) PET imaging. The reported probe 68Ga-DPI-4452 strongly targets both hCAIX and hCAII, therefore hindering its clinical applications. This study developed two optimized probes, 68Ga-WF1 and 68Ga-WF2. They have nanomolar affinity...

Fu-Hai Wu, Zhen Chen, Huang-You Chen et al. · 0 citations
Nov 2026

Tunable 18F-Labeling of Erlotinib-Based Small Molecule Nanodrugs for Rapid PET Imaging and Targeted Therapy.

Small molecule nanodrugs (SMNs) offer unique advantages for cancer therapy, yet accurately tracking their in vivo fate without perturbing their native assembly remains challenging. Here, we report a spacer engineering strategy that enables efficient 1 8F-labeling while preserving SMNs self-assembly. Erlotinib-based amp...

Jia-Feng Li, Yi-Ru Jiang, Ji-Wei Cui et al. · 0 citations
Sep 2026

A Biphenyl-Containing Dimeric Sulfonamide PET Tracer for High-Contrast Imaging of Carbonic Anhydrase IX in Clear Cell Renal Cell Carcinoma.

Carbonic Anhydrase IX (CAIX) is an attractive biomarker for clear cell renal cell carcinoma (ccRCC), but small-molecule CAIX radiotracers are often limited by insufficient tumor retention and suboptimal tumor-to-kidney contrast. Herein, we report the rational design of biphenyl-containing bivalent sulfonamide tracers a...

Yi-Min Chen, Wan-Jia Liu, Ben Li et al. · 0 citations
Oct 2026

HER2-Targeting Affibody Equipped with Albumin-Binding Small Molecules for Radiotheranostics

HER2-targeting affibody radioprobes are often limited by rapid systemic clearance and excessive renal accumulation. Herein, we develop a modular chemical strategy to optimize the pharmacokinetic properties of affibodies through conjugation of small-molecule albumin-binding motifs (ABMs). Enabled by our selective S-gl...

Wei-Chen Wang, Ao Shen, Ming-Xing Huang et al. · 0 citations
Oct 2026

Preclinical Evaluation of 68Ga-Labeled Heterodimers for Dual Integrin αvβ3 and PARP1-Targeted Tumor Imaging.

Tumor heterogeneity limits the diagnostic performance of molecular imaging probes targeting a single biomarker. Here, we report the design, synthesis, and preclinical evaluation of 68Ga-labelled heterodimeric radiotracers co-targeting integrin αvβ3 and poly(ADP-ribose) polymerase 1 (PARP1) through a proposed "binding-a...

Cong-Jie He, Yun-Long Li, Peng-Fei Dai et al. · 0 citations
Sep 2026

Development and Preclinical Evaluation of [68Ga]Ga-DOTA-L3: A Novel PET Tracer for Quantitative Imaging of Carbonic Anhydrase IX.

Carbonic anhydrase IX (CA IX) is a key biomarker for tumor hypoxia and a promising target for molecular imaging. In this study, we developed [68Ga]Ga-DOTA-L3, a novel small-molecule CA IX-targeted PET tracer. The radiolabeling was optimized to consistently achieve a radiochemical purity of >98% (10 μg precursor, 90 °C,...

Jie Li, Yu-Hui Luo, Cheng-Yu Luo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.